The Function of Drug Company Representatives
- 1 September 1977
- journal article
- research article
- Published by SAGE Publications in Scandinavian Journal of Social Medicine
- Vol. 5 (3) , 105-114
- https://doi.org/10.1177/140349487700500301
Abstract
The drug industry has a major influence on drug prescribing habits through their medical representatives. We therefore set out to see whether their work was more concerned with providing information or with selling, more with demand or with supply, and how much it cost in Finland. We interviewed currently employed and former representatives and contact persons in health institutions, and analysed advertisements for vacancies for medical representatives. It seems that companies regard detailing more as a sales activity than as public relations and that this trend towards selling has gained in importance in recent years. The number of representatives engaged in the pharmaceutical industry exceeds the demand for their services. The drug companies allotted in 1975 detailing at least 5000 Fmk ($1300) per physician per year. Our conclusion is that drug detailing is neither necessary nor beneficial for the health services.Keywords
This publication has 15 references indexed in Scilit:
- Prescribing influences: an overview1Medical Education, 2009
- An inquiry into associations between leading physicians and the drug industry in FinlandSocial Science & Medicine (1967), 1977
- Content analysis of drug-detailing by pharmaceutical representativesMedical Education, 1977
- Factors Influencing Drug Prescribing — Inquiry into Research StrategyDrug Intelligence & Clinical Pharmacy, 1976
- Review of literature on the factors affecting drug prescribingSocial Science & Medicine (1967), 1975
- Physician's orientation toward the legitimacy of drug use and their preferred source of new drug informationSocial Science & Medicine (1967), 1972
- Doctor's Choice: The Physician and His Sources of Information about DrugsJournal of Marketing Research, 1966
- Communication and Opinion Formation in a Medical Community: The Significance of The Detail Man.The Academy of Management Journal, 1965
- The Drug House RepresentativeSociological Review, 1964